Patents by Inventor Richard H. Ingraham

Richard H. Ingraham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6890925
    Abstract: Disclosed are methods of using soluble epoxide hydrolase (sEH) inhibitors of the formulas I and Ia for diseases related to cardiovascular disease.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: May 10, 2005
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Richard H. Ingraham, John R. Proudfoot
  • Patent number: 6831082
    Abstract: Disclosed are novel compounds of the formula Ia and methods of using soluble epoxide hydrolase (sEH) inhibitors of the formulas I and Ia for diseases related to cardiovascular disease.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: December 14, 2004
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Richard H. Ingraham, John R. Proudfoot
  • Publication number: 20040092567
    Abstract: Disclosed are methods of using soluble epoxide hydrolase (sEH) inhibitors of the formulas I and Ia for diseases related to cardiovascular disease.
    Type: Application
    Filed: September 25, 2003
    Publication date: May 13, 2004
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc
    Inventors: Richard H. Ingraham, John R. Proudfoot
  • Publication number: 20030022929
    Abstract: Disclosed are novel compounds of the formula Ia and methods of using soluble epoxide hydrolase (sEH) inhibitors of the formulas I and Ia for diseases related to cardiovascular disease.
    Type: Application
    Filed: June 14, 2002
    Publication date: January 30, 2003
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Richard H. Ingraham, John R. Proudfoot